緑内障治療薬とは、原発性閉塞隅角（PAC）緑内障および原発性開放隅角（POA）緑内障に対する様々な代替治療法を指します。緑内障は、視神経の構造変化によって引き起こされ、失明や視野欠損につながることが多い病気です。緑内障の治療を開始する際には、主にβ遮断薬、プロスタグランジンアナログ、コリン作動薬、炭酸脱水酵素阻害薬、αアドレナリン作動薬などを含む外用点眼薬を使用することができます。これらの点眼薬は、目の中で発生する液体の量を減らし、眼圧（IOP）を低下させます。埋め込み型徐放性デバイス、薬剤溶出涙点プラグ、ポリマーベースコンタクトレンズ、マイクロニードル注入デバイス、マイクロドージング技術などのデバイスの使用後に、従来の外科的処置またはレーザー手術、あるいはその両方の組み合わせが行われます。市場の成長を促す主な要因の1つは、世界的に緑内障の発症率が上昇していることです。糖尿病や加齢黄斑変性症（AMD）、白内障、ドライアイなどの眼疾患を持つ患者は、緑内障を発症する可能性が非常に高いとされています。また、眼科領域における技術の進歩も市場拡大の要因であり、製品の革新や開発が進み、市場の需要が高まると予想されます。
緑内障治療薬の世界市場の成長を促進すると予測される主な要因は、失明の発生率の上昇と緑内障患者数の増加です。国際失明予防協会（The International Agency for the Prevention of Blindness）の報告によると、2020年には8,000万人が緑内障に罹患し、2010年のデータ調査結果から約2,000万人増加するとされています。さらに、高齢者人口の増加は、予測期間中に市場に有利な機会を生み出すと予想されます。ただし、主要なプレーヤーによる医薬品のリコールは、2022年から2029年の予測期間を通じて市場の成長を抑制しました。
緑内障治療薬の世界市場の調査対象地域は、アジア太平洋地域、北アメリカ、ヨーロッパ、ラテンアメリカ、その他の地域です。北アメリカは、医療インフラが整備されていることや緑内障の有病率が上昇していることから、市場シェアでは世界の主要地域となっています。一方、アジア太平洋地域は、糖尿病の有病率の上昇、眼疾患の増加、失明者や視覚障害者の増加などの要因により、予測期間中に最高の成長率を示すと予想され、アジア太平洋地域全体で緑内障治療薬市場に有利な成長見通しを創出します。
本調査の目的は、近年における様々なセグメント・国の市場規模を定義し、今後数年間の価値を予測することです。本レポートは、調査対象国における産業の質的・量的な側面を取り込むように設計されています。
さらに、市場の今後の成長を決定づける推進要因や課題などの重要な側面に関する詳細情報も提供しています。さらに、主要企業の競争環境と製品提供の詳細な分析とともに、利害関係者が投資するためのミクロ市場の潜在的な機会も組み込んでいます。
目次
Table of Contents
Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Billion)
1.2.1. Glaucoma Therapeutics Market, by Region, 2019-2029 (USD Billion)
1.2.2. Glaucoma Therapeutics Market, by Drug Class, 2019-2029 (USD Billion)
1.2.3. Glaucoma Therapeutics Market, by Disease Indication, 2019-2029 (USD Billion)
1.2.4. Glaucoma Therapeutics Market, by Distribution Channel, 2019-2029 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Glaucoma Therapeutics Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Glaucoma Therapeutics Market Dynamics
3.1. Glaucoma Therapeutics Market Impact Analysis (2019-2029)
3.1.1. Market Drivers
3.1.1.1. Rising incidence of glaucoma
3.1.1.2. Increasing technological advancements
3.1.2. Market Challenges
3.1.2.1. Drug recalls by major players
3.1.3. Market Opportunities
3.1.3.1. Rising geriatric population
Chapter 4. Global Glaucoma Therapeutics Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.2. Futuristic Approach to Porter’s 5 Force Model (2019-2029)
4.3. PEST Analysis
4.3.1. Political
4.3.2. Economical
4.3.3. Social
4.3.4. Technological
4.4. Top investment opportunity
4.5. Top winning strategies
4.6. Industry Experts Prospective
4.7. Analyst Recommendation & Conclusion
Chapter 5. Risk Assessment: COVID-19 Impact
5.1. Assessment of the overall impact of COVID-19 on the industry
5.2. Pre COVID-19 and post COVID-19 Market scenario
Chapter 6. Global Glaucoma Therapeutics Market, by Drug Class
6.1. Market Snapshot
6.2. Global Glaucoma Therapeutics Market by Drug Class, Performance - Potential Analysis
6.3. Global Glaucoma Therapeutics Market Estimates & Forecasts by Drug Class 2019-2029 (USD Billion)
6.4. Glaucoma Therapeutics Market, Sub Segment Analysis
6.4.1. Beta Blockers
6.4.2. Prostaglandins Analogs
6.4.3. Alpha Adrenergic Agonists
6.4.4. Carbonic Anhydrase Inhibitors
6.4.5. Combination Drugs
Chapter 7. Global Glaucoma Therapeutics Market, by Disease Indication
7.1. Market Snapshot
7.2. Global Glaucoma Therapeutics Market by Disease Indication, Performance - Potential Analysis
7.3. Global Glaucoma Therapeutics Market Estimates & Forecasts by Disease Indication 2019-2029 (USD Billion)
7.4. Glaucoma Therapeutics Market, Sub Segment Analysis
7.4.1. Open Angle Glaucoma
7.4.2. Angle Closure Glaucoma
Chapter 8. Global Glaucoma Therapeutics Market, by Distribution Channel
8.1. Market Snapshot
8.2. Global Glaucoma Therapeutics Market by Distribution Channel, Performance - Potential Analysis
8.3. Global Glaucoma Therapeutics Market Estimates & Forecasts by Distribution Channel 2019-2029 (USD Billion)
8.4. Glaucoma Therapeutics Market, Sub Segment Analysis
8.4.1. Hospital Pharmacy
8.4.2. Retail Pharmacy
8.4.3. Online Pharmacy
Chapter 9. Global Glaucoma Therapeutics Market, Regional Analysis
9.1. Glaucoma Therapeutics Market, Regional Market Snapshot
9.2. North America Glaucoma Therapeutics Market
9.2.1. U.S. Glaucoma Therapeutics Market
9.2.1.1. Drug Class breakdown estimates & forecasts, 2019-2029
9.2.1.2. Disease Indication breakdown estimates & forecasts, 2019-2029
9.2.1.3. Distribution Channel breakdown estimates & forecasts, 2019-2029
9.2.2. Canada Glaucoma Therapeutics Market
9.3. Europe Glaucoma Therapeutics Market Snapshot
9.3.1. U.K. Glaucoma Therapeutics Market
9.3.2. Germany Glaucoma Therapeutics Market
9.3.3. France Glaucoma Therapeutics Market
9.3.4. Spain Glaucoma Therapeutics Market
9.3.5. Italy Glaucoma Therapeutics Market
9.3.6. Rest of Europe Glaucoma Therapeutics Market
9.4. Asia-Pacific Glaucoma Therapeutics Market Snapshot
9.4.1. China Glaucoma Therapeutics Market
9.4.2. India Glaucoma Therapeutics Market
9.4.3. Japan Glaucoma Therapeutics Market
9.4.4. Australia Glaucoma Therapeutics Market
9.4.5. South Korea Glaucoma Therapeutics Market
9.4.6. Rest of Asia Pacific Glaucoma Therapeutics Market
9.5. Latin America Glaucoma Therapeutics Market Snapshot
9.5.1. Brazil Glaucoma Therapeutics Market
9.5.2. Mexico Glaucoma Therapeutics Market
9.5.3. Rest of Latin America Glaucoma Therapeutics Market
9.6. Rest of The World Glaucoma Therapeutics Market
Chapter 10. Competitive Intelligence
10.1. Top Market Strategies
10.2. Company Profiles
10.2.1. Deep Dive
10.2.1.1. Key Information
10.2.1.2. Overview
10.2.1.3. Financial (Subject to Data Availability)
10.2.1.4. Product Summary
10.2.1.5. Recent Developments
10.2.2. Allergan Plc
10.2.3. Merck & Co., Inc.
10.2.4. Akorn, Operating Company LLC
10.2.5. Bausch & Lomb Incorporated
10.2.6. Oculis S.A.
10.2.7. Teva Pharmaceuticals Industries Ltd
10.2.8. Alcon
10.2.9. Pfizer Inc
10.2.10. Nanodropper, Inc.
Chapter 11. Research Process
11.1. Research Process
11.1.1. Data Mining
11.1.2. Analysis
11.1.3. Market Estimation
11.1.4. Validation
11.1.5. Publishing
11.2. Research Attributes
11.3. Research Assumption
List of Tables
TABLE 1. Global Glaucoma Therapeutics Market, report scope
TABLE 2. Global Glaucoma Therapeutics Market estimates & forecasts by Region 2019-2029 (USD Billion)
TABLE 3. Global Glaucoma Therapeutics Market estimates & forecasts by Drug Class 2019-2029 (USD Billion)
TABLE 4. Global Glaucoma Therapeutics Market estimates & forecasts by Disease Indication 2019-2029 (USD Billion)
TABLE 5. Global Glaucoma Therapeutics Market estimates & forecasts by Distribution Channel 2019-2029 (USD Billion)
TABLE 6. Global Glaucoma Therapeutics Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 7. Global Glaucoma Therapeutics Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 8. Global Glaucoma Therapeutics Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 9. Global Glaucoma Therapeutics Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 10. Global Glaucoma Therapeutics Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 11. Global Glaucoma Therapeutics Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 12. Global Glaucoma Therapeutics Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 13. Global Glaucoma Therapeutics Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 14. Global Glaucoma Therapeutics Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 15. Global Glaucoma Therapeutics Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 16. U.S. Glaucoma Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 17. U.S. Glaucoma Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 18. U.S. Glaucoma Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 19. Canada Glaucoma Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 20. Canada Glaucoma Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 21. Canada Glaucoma Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 22. UK Glaucoma Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 23. UK Glaucoma Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 24. UK Glaucoma Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 25. Germany Glaucoma Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 26. Germany Glaucoma Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 27. Germany Glaucoma Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 28. France Glaucoma Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 29. France Glaucoma Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 30. France Glaucoma Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 31. Italy Glaucoma Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 32. Italy Glaucoma Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 33. Italy Glaucoma Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 34. Spain Glaucoma Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 35. Spain Glaucoma Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 36. Spain Glaucoma Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 37. RoE Glaucoma Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 38. RoE Glaucoma Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 39. RoE Glaucoma Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 40. China Glaucoma Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 41. China Glaucoma Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 42. China Glaucoma Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 43. India Glaucoma Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 44. India Glaucoma Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 45. India Glaucoma Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 46. Japan Glaucoma Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 47. Japan Glaucoma Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 48. Japan Glaucoma Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 49. South Korea Glaucoma Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 50. South Korea Glaucoma Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 51. South Korea Glaucoma Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 52. Australia Glaucoma Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 53. Australia Glaucoma Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 54. Australia Glaucoma Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 55. RoAPAC Glaucoma Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 56. RoAPAC Glaucoma Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 57. RoAPAC Glaucoma Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 58. Brazil Glaucoma Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 59. Brazil Glaucoma Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 60. Brazil Glaucoma Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 61. Mexico Glaucoma Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 62. Mexico Glaucoma Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 63. Mexico Glaucoma Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 64. RoLA Glaucoma Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 65. RoLA Glaucoma Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 66. RoLA Glaucoma Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 67. Row Glaucoma Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 68. Row Glaucoma Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 69. Row Glaucoma Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 70. List of secondary sources, used in the study of global Glaucoma Therapeutics Market
TABLE 71. List of primary sources, used in the study of global Glaucoma Therapeutics Market
TABLE 72. Years considered for the study
TABLE 73. Exchange rates considered
List of tables and figures and dummy in nature, final lists may vary in the final deliverable
List of figures
FIG 1. Global Glaucoma Therapeutics Market, research methodology
FIG 2. Global Glaucoma Therapeutics Market, Market estimation techniques
FIG 3. Global Market size estimates & forecast methods
FIG 4. Global Glaucoma Therapeutics Market, key trends 2021
FIG 5. Global Glaucoma Therapeutics Market, growth prospects 2022-2029
FIG 6. Global Glaucoma Therapeutics Market, porters 5 force model
FIG 7. Global Glaucoma Therapeutics Market, pest analysis
FIG 8. Global Glaucoma Therapeutics Market, value chain analysis
FIG 9. Global Glaucoma Therapeutics Market by segment, 2019 & 2029 (USD Billion)
FIG 10. Global Glaucoma Therapeutics Market by segment, 2019 & 2029 (USD Billion)
FIG 11. Global Glaucoma Therapeutics Market by segment, 2019 & 2029 (USD Billion)
FIG 12. Global Glaucoma Therapeutics Market by segment, 2019 & 2029 (USD Billion)
FIG 13. Global Glaucoma Therapeutics Market by segment, 2019 & 2029 (USD Billion)
FIG 14. Global Glaucoma Therapeutics Market, regional snapshot 2019 & 2029
FIG 15. North America Glaucoma Therapeutics Market 2019 & 2029 (USD Billion)
FIG 16. Europe Glaucoma Therapeutics Market 2019 & 2029 (USD Billion)
FIG 17. Asia pacific Glaucoma Therapeutics Market 2019 & 2029 (USD Billion)
FIG 18. Latin America Glaucoma Therapeutics Market 2019 & 2029 (USD Billion)
FIG 19. Global Glaucoma Therapeutics Market, company Market share analysis (2021)
List of tables and figures and dummy in nature, final lists may vary in the final deliverable
